What does DR. MAX SCHREUER, MEDISCH ONCOLOOG do?

DR. MAX SCHREUER, MEDISCH ONCOLOOG is a specialist medical practice in Destelbergen. Private Limited, started on 18 February 2022, 1 establishment.

What is the address of DR. MAX SCHREUER, MEDISCH ONCOLOOG?

The registered office of DR. MAX SCHREUER, MEDISCH ONCOLOOG is located at Eyloschlaan 18, 9070 Destelbergen.

Is DR. MAX SCHREUER, MEDISCH ONCOLOOG still active?

Yes. According to the CBE (18 September 2026) DR. MAX SCHREUER, MEDISCH ONCOLOOG is active, legal situation “Normale toestand”, started on 18 February 2022.

Is DR. MAX SCHREUER, MEDISCH ONCOLOOG registered on Peppol?

Yes, DR. MAX SCHREUER, MEDISCH ONCOLOOG is registered on the Peppol network with ID 0208:0782349639.

What is the enterprise number of DR. MAX SCHREUER, MEDISCH ONCOLOOG?

The enterprise number of DR. MAX SCHREUER, MEDISCH ONCOLOOG is BE0782349639.

When was DR. MAX SCHREUER, MEDISCH ONCOLOOG founded?

DR. MAX SCHREUER, MEDISCH ONCOLOOG was founded on 18 February 2022.

Who are the directors of DR. MAX SCHREUER, MEDISCH ONCOLOOG?

According to the 2025 annual accounts, the directors of DR. MAX SCHREUER, MEDISCH ONCOLOOG are: Max Schreuer.

Is DR. MAX SCHREUER, MEDISCH ONCOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MAX SCHREUER, MEDISCH ONCOLOOG make in 2025?

DR. MAX SCHREUER, MEDISCH ONCOLOOG posted a profit after taxes of € 175,400 in financial year 2025.

What is the revenue of DR. MAX SCHREUER, MEDISCH ONCOLOOG?

As a small company, DR. MAX SCHREUER, MEDISCH ONCOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 196,703.

DR. MAX SCHREUER, MEDISCH ONCOLOOG (Private Limited)

Dossier DR. MAX SCHREUER, MEDISCH ONCOLOOG, printed on 18 September 2026 from databakkes.be/en/0782349639/dr-max-schreuer-medisch-oncoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MAX SCHREUER, MEDISCH ONCOLOOG from Destelbergen, company number BE0782349639, closed financial year 2025 with a result of € 175,400 after tax. For that financial year DR. MAX SCHREUER, MEDISCH ONCOLOOG recorded a gross margin of € 196,703 and equity of € 258,297. Compared with financial year 2024, the result moved from € 215,703 to € 175,400. The company is profitable. The buffer shrank hard: equity is 58 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Shrank hard

€ 258,297

▼ 58% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 175,400

▼ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 108,317

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 535,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

€ 16,836

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,972

▲ € 1,880 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 146,338

▲ 122% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 236,790 Gross margin 2022: € 236,790 First fiscal year in the series	€ 285,748 Gross margin 2023: € 285,748 ▲ 21% vs 2022 (€ 236,790) Favourable step	€ 274,839 Gross margin 2024: € 274,839 ▼ 4% vs 2023 (€ 285,748) Unfavourable step	€ 196,703 Gross margin 2025: € 196,703 ▼ 28% vs 2024 (€ 274,839) Unfavourable step	▼ 28%
Profit after taxes	€ 181,077 Profit after taxes 2022: € 181,077 First fiscal year in the series	€ 218,616 Profit after taxes 2023: € 218,616 ▲ 21% vs 2022 (€ 181,077) Favourable step	€ 215,703 Profit after taxes 2024: € 215,703 ▼ 1% vs 2023 (€ 218,616) Unfavourable step	€ 175,400 Profit after taxes 2025: € 175,400 ▼ 19% vs 2024 (€ 215,703) Unfavourable step	▼ 19%
Equity	€ 183,577 Equity 2022: € 183,577 First fiscal year in the series	€ 402,193 Equity 2023: € 402,193 ▲ 119% vs 2022 (€ 183,577) Favourable step	€ 617,897 Equity 2024: € 617,897 ▲ 54% vs 2023 (€ 402,193) Favourable step	€ 258,297 Equity 2025: € 258,297 ▼ 58% vs 2024 (€ 617,897) Unfavourable step	▼ 58%
Total debts	€ 64,906 Total debts 2022: € 64,906 First fiscal year in the series	€ 68,434 Total debts 2023: € 68,434 ▲ 5% vs 2022 (€ 64,906) Unfavourable step	€ 66,021 Total debts 2024: € 66,021 ▼ 4% vs 2023 (€ 68,434) Favourable step	€ 165,146 Total debts 2025: € 165,146 ▲ 150% vs 2024 (€ 66,021) Unfavourable step	▲ 150%
Cash	€ 247,434 Cash 2022: € 247,434 First fiscal year in the series	€ 461,703 Cash 2023: € 461,703 ▲ 87% vs 2022 (€ 247,434) Favourable step	€ 107,820 Cash 2024: € 107,820 ▼ 77% vs 2023 (€ 461,703) Unfavourable step	€ 108,317 Cash 2025: € 108,317 Unchanged (€ 107,820) Favourable step
Retained profit	€ 181,077 Retained profit 2022: € 181,077 First fiscal year in the series	€ 399,693 Retained profit 2023: € 399,693 ▲ 121% vs 2022 (€ 181,077) Favourable step	€ 615,397 Retained profit 2024: € 615,397 ▲ 54% vs 2023 (€ 399,693) Favourable step	€ 255,797 Retained profit 2025: € 255,797 ▼ 58% vs 2024 (€ 615,397) Unfavourable step	▼ 58%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 535,000 Dividend 2025: € 535,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 16,836 Bank debt 2025: € 16,836 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 248,483 Balance sheet total 2022: € 248,483 First fiscal year in the series	€ 470,627 Balance sheet total 2023: € 470,627 ▲ 89% vs 2022 (€ 248,483) Unchanged	€ 683,917 Balance sheet total 2024: € 683,917 ▲ 45% vs 2023 (€ 470,627) Unchanged	€ 423,442 Balance sheet total 2025: € 423,442 ▼ 38% vs 2024 (€ 683,917) Unchanged	▼ 38%

Key figures of DR. MAX SCHREUER, MEDISCH ONCOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MAX SCHREUER, MEDISCH ONCOLOOG?

What happened at DR. MAX SCHREUER, MEDISCH ONCOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 175,400 (▼ 19% vs 2024). Source: NBB ↗
Feb 18, 2022 New establishment in Aalst. KBO
2022 Max Schreuer became a director. NBB
Feb 18, 2022 Start of the company according to the CBE. KBO

In short

From € 181,077 profit in 2022 to € 175,400 profit in 2025.

Paid € 236,760 in corporate taxes since 2022.

Best year ever: 2023, with € 218,616 profit.

Paid out € 535,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. MAX SCHREUER, MEDISCH ONCOLOOG? We notify you, reason included.

Follow DR. MAX SCHREUER, MEDISCH ONCOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit